ResMed Inc. RMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.04% | 9.85% | 10.28% | 9.57% | 9.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.04% | 9.85% | 10.28% | 9.57% | 9.36% |
| Cost of Revenue | 6.03% | 5.75% | 3.03% | 3.40% | 3.55% |
| Gross Profit | 11.00% | 12.59% | 15.24% | 13.85% | 13.51% |
| SG&A Expenses | 10.74% | 13.01% | 12.78% | 10.98% | 9.64% |
| Depreciation & Amortization | -1.46% | -25.74% | -20.41% | -22.12% | -24.43% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.23% | 7.94% | 5.97% | 5.53% | 5.11% |
| Operating Income | 10.66% | 13.78% | 19.41% | 18.27% | 18.89% |
| Income Before Tax | 15.56% | 14.42% | 20.67% | 18.48% | 26.51% |
| Income Tax Expenses | 38.17% | 43.09% | 45.36% | 16.26% | 15.10% |
| Earnings from Continuing Operations | 10.80% | 8.75% | 15.71% | 18.99% | 29.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.80% | 8.75% | 15.71% | 18.99% | 29.21% |
| EBIT | 10.66% | 13.78% | 19.41% | 18.27% | 18.89% |
| EBITDA | 9.70% | 12.65% | 20.11% | 18.26% | 18.76% |
| EPS Basic | 12.22% | 9.65% | 16.40% | 19.47% | 29.56% |
| Normalized Basic EPS | 14.71% | 17.39% | 22.84% | 21.33% | 23.21% |
| EPS Diluted | 12.40% | 9.69% | 16.39% | 19.37% | 29.43% |
| Normalized Diluted EPS | 14.87% | 17.50% | 22.91% | 21.37% | 23.17% |
| Average Basic Shares Outstanding | -1.25% | -0.82% | -0.59% | -0.40% | -0.29% |
| Average Diluted Shares Outstanding | -1.39% | -0.91% | -0.64% | -0.43% | -0.25% |
| Dividend Per Share | 12.33% | 13.21% | 12.56% | 11.88% | 11.17% |
| Payout Ratio | 0.00% | 0.03% | -0.03% | -0.06% | -0.14% |